Next Article in Journal
Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells
Next Article in Special Issue
Transcriptome and Metabolome Analyses Reveal the Mechanism of Corpus Luteum Cyst Formation in Pigs
Previous Article in Journal
RNA-Seq Identified Putative Genes Conferring Photosynthesis and Root Development of Melon under Salt Stress
Previous Article in Special Issue
Transcriptomic Analysis of the Developing Testis and Spermatogenesis in Qianbei Ma Goats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Salidroside Supplementation Affects In Vitro Maturation and Preimplantation Embryonic Development by Promoting Meiotic Resumption

1
Jilin Provincial Key Laboratory of Animal Model, College of Animal Science, Jilin University, Changchun 130062, China
2
Animal Genome Editing Technology Innovation Center, College of Animal Science, Jilin University, Changchun 130062, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Genes 2023, 14(9), 1729; https://doi.org/10.3390/genes14091729
Submission received: 9 August 2023 / Revised: 24 August 2023 / Accepted: 27 August 2023 / Published: 30 August 2023
(This article belongs to the Special Issue Genetic Regulation of Animal Reproduction)

Abstract

:

Simple Summary

The in vitro maturation (IVM) of oocytes is often delayed due to oxidative stress and mitochondrial function, resulting in a decrease in oocyte quality. We used a porcine oocyte model to check the effects of salidroside supplementation during IVM on the quality and developmental competence of oocytes. Using a variety of experimental methods, the efficiency of salidroside in protecting mature oocytes, apoptosis, and mitochondrial function was observed.

Abstract

Salidroside (Sal) possesses several pharmacological activities, such as antiaging, and anti-inflammatory, antioxidant, anticancer activities, and proliferation-promoting activities, but the effects of Sal on oocytes have rarely been reported. In the present study, we evaluated the beneficial effects of Sal, which is mainly found in the roots of Rhodiola. Porcine cumulus oocyte complexes were cultured in IVM medium supplemented (with 250 μmol/L) with Sal or not supplemented with Sal. The maturation rate in the Sal group increased from 88.34 ± 4.32% to 94.12 ± 2.29%, and the blastocyst rate in the Sal group increased from 30.35 ± 3.20% to 52.14 ± 7.32% compared with that in the control group. The experimental groups showed significant improvements in the cumulus expansion area. Sal reduced oocyte levels of reactive oxygen species (ROS) and enhanced intracellular GSH levels. Sal supplementation enhanced the mitochondrial membrane potential (MMP), ATP level, and mtDNA copy number, which shows that Sal enhances the cytoplasmic maturation of oocytes. Oocytes in the Sal group exhibited slowed apoptosis and reduced DNA breakage. Cell cycle signals and oocyte meiosis play important roles in oocyte maturation. The mRNA expressions of the MAPK pathway and MAPK phosphorylation increased significantly in the Sal group. The mRNA expression of the oocyte meiosis gene also increased significantly. These results show that Sal enhances the nuclear maturation of oocytes. Moreover, Sal increased the number of blastocyst cells, the proliferation of blastocysts, and the expressions of pluripotency genes. Sal down-regulated apoptosis-related genes and the apoptotic cell rate of blastocysts. In summary, our results demonstrate that Sal is helpful to improving the quality of porcine oocytes in vitro, and their subsequent embryonic development.

1. Introduction

In vitro porcine embryo production (IVP) is now being used in the development of gamete/embryo biology and agriculture, as well as in the production of cloned and transgenic pigs. Therefore, it has certain advantages for research and commercial use [1,2]. Even though the porcine in vitro maturation system has been established, the maturation rate is not ideal. Due to its sensitivity to the in vitro maturation environment, the quality of oocytes plays a decisive role in embryo quality, and it is necessary to further improve the maturation rate [3,4], lay a foundation for the improvement of human embryo reproduction technology, and strengthen its application in agriculture and medical research [5].
In vitro maturation (IVM) is a complex process controlled by multiple intrinsic and extrinsic factors, studies in mice have shown that perturbations of mitochondrial function affect the maturation of oocytes [6]. Oxidative stress has become a damaging factor of oocytes [7]. Currently, to promote the production of in vitro embryos, supplements are used during the in vitro maturation of oocytes such as antioxidants, which can counteract some of the negative effects of oxidative stress [8]. Mitogen-activated protein kinases (MAPKs) are serine/threonine protein kinases that widely exist in mammalian cells [9]. The MAPK signaling pathway plays an important role in cell proliferation, differentiation, cell survival, and apoptosis [10]. During the process of oocyte maturation, MAPK maintains the stability of the spindle structure and promotes oocyte maturation [5].
Sal is mainly found in the roots of Rhodiola. It has been extensively used for medicinal purposes, because it has many biological and pharmacological properties, and has many active properties [11], such as anticancer [12], antioxidant [13], antiaging, antidiabetic, antidepression, antilipid, anti-inflammatory immune regulation [14], promoting multiplication, and so on [15]. Sal influences the PI3K/Akt, AMPK and MEK/ERK pathways, which are the main reasons for its promotion of proliferation [15,16]. Sal has well-documented beneficial biological and physiological functions such as anticancer, anti-oxidative, and slowing down apoptosis. However, there is little information available in the literature on the mode of action of Sal during oocyte IVM.
Therefore, we hypothesized that Sal would enhance the developmental potential of oocytes because it has a protective effect. More importantly, the molecular mechanisms by which Sal affect oocyte maturation are still unknown. In this study, we used pigs as a model for evaluating whether adding Sal to the culture medium can improve IVM oocyte quality and subsequent embryonic development. We first examined the first polar body excretion and parthenogenetic activation of embryonic development, and then assessed oocytes and preimplantation embryos’ molecular changes, factors affecting cytoplasmic maturation including ROS levels, mitochondrial membrane potential (MMP), and mtDNA copy number, factors affecting nuclear maturation including proliferation and apoptosis levels, and MAPK level changes.

2. Materials and Methods

All reagents except those specially marked were purchased from Sigma Aldrich (St. Louis, MO, USA).

2.1. Oocyte Collection and Culture

Porcine ovaries were collected from the local slaughterhouse, and then transported to the laboratory in 37 °C 0.9% saline in a thermos. Follicular fluid was extracted from these 3–6 mm follicles using a syringe with a 1.2 mm needle, and collected under a stereomicroscope (SMZ800N, Nikon, Tokyo, Japan). This experiment used cumulus oocyte complexes (COCs), which are oocytes with three or more layers of cumulus cells that are evenly distributed on the surface. The subsequent COCs were washed three times in medium 199 containing HEPES (GIBCO, Waltham, MA, USA, 12350039), 0.1% PVA, and cultured in IVM (tissue culture medium 199 supplemented with 0.6 mM L-cysteine, 0.91 mM Na pyruvate, 10 ng/mL EGF, 10% porcine follicular fluid, 10 IU/mL follicle-stimulating hormone, 10 IU/mL luteinizing hormone, and 0.1% penicillin streptomycin), and in order to explore the optimal dosing concentration of the treatment group, 50 oocytes were placed in 500 μL of IVM supplemented with 50 μM, 250 μM, and 400 μM Sal. They were equally divided into treated and untreated groups, and were added to the treatment group of 250 μM Sal covered with mineral oil incubate in 38.5 °C under 5% CO2 and 100% moisture for 42 h. A picture for each COC was taken before and at the end of the in vitro culture, and the cumulus expansion was calculated as the ratio between the final cumulus area and the initial cumulus area. The cumulus area was measured by analysis via NIH ImageJ software 1.52a (National Institutes of Health, Bethesda, MD, USA).

2.2. Parthenogenetic Activation

The cumulus cells were removed with 0.1% hyaluronidase, and the oocytes without cumulus cells were treated in 5 mm ionomycin (pzm-5 configuration) for 5 min, then washed in pzm-5 three times. Then, the embryos were placed in bicarbonate-buffered porcine zygote medium 5 (PZM-5) containing 0.4 mg/mL bovine serum albumin (BSA) and 7.5 μg/mL CB for 4 h to inhibit the excretion of the pseudo-second polar body. The blastocyst rates and diameters were analyzed on day 6, and the blastocyst diameters were analyzed via NIH ImageJ software 1.52a (National Institutes of Health, Bethesda, MD, USA).

2.3. Count the Number of Cells in the Blastocyst

To quantify the total number of cells in the blastocysts, the blastocysts of the treatment group and untreated group on the seventh day were selected and fixed with 4% paraformaldehyde with pH = 7.4. Then, the fixed blastocysts were washed with PBS–PVA (0.1% PVA) three times, and placed into the permeabilization solution containing 0.5% TritonX-100 for 20 min at room temperature. The blastocysts were again washed with PBS–PVA three times; the 5 ng/mL Hoechst 33,342 stained nuclei were incubated at room temperature for 10 min, then gently placed on slides and sealed with an anti-fluorescence quencher. Next, the blastocysts were gently mounted onto glass slides and examined under a fluorescence microscope (IX73, Olympus, Tokyo, Japan). NIH ImageJ software was used to analyze the total number of nuclei.

2.4. Evaluation of ROS and GSH Levels in Oocytes

To measure the ROS and GSH levels in the M2 oocytes of the treatment group and untreated group, the M2 oocytes in each group were divided into four groups and cultured in PBS–BSA medium containing 10 mM 20, 70-dichlorodihydrofluorescein diacetate (Thermo Fisher Scientific, Waltham, MA, USA, C400), and 10 mM 4-chloromethyl-6,8-difluoro-7-hydroxycoumarin (Thermo Fisher Scientific, C12881) for 15 and 30 min. Then, the oocytes were washed with 0.1% PBS–BSA for 3 times. A digital camera (E179168; Nikon) was connected to a fluorescence microscope to take pictures, with the fluorescence photos saved as TIFF files, and the fluorescence intensity was analyzed using NIH ImageJ software.

2.5. Mitochondrial Membrane Potential Assay

To measure the mitochondrial membrane potential (MMP), M2-stage oocytes were washed three times with PBS–PVA, and then washed with 2 mM 5,50,6,60-tetrachloro-1,10,3,30-tetraethyl-imidacarbocyanine iodide (JC-1, Beyotime, Haimen, China) for 30 min. The oocytes were again washed three times with PBS–PVA, and a fluorescence microscope was used to connect to the camera and capture the red/green fluorescence signal. The MMP was calculated as the ratio of red fluorescence and analyzed according to the manufacturer’s instructions. The fluorescence intensity of the images was processed and measured using NIH ImageJ software.

2.6. Determination of ATP Content

The oocyte ATP content was determined using an Enhanced ATP Assay Kit (Beyotime, China) according to the manufacturer’s instructions, and the results are shown in the microplate reader.

2.7. Mitochondrial Copy Number Detection

The total DNA was extracted from 200 MII-stage oocytes using a DNA isolation kit (QIAGEN, Hilden, Germany, 80284) according to the instructions. Through fluorescence quantification to detect the mitochondrial copy number, its principle is to extract mitochondrial ATP6, ND1, and COX1 genes, and the nuclear single-copy gene GCG was used to detect the relative concentrations of the mitochondrial and nuclear genomes. Since the genes in mitochondria are single-copy genes, the mitochondrial gene and single-copy nuclear gene relative concentration ratio can be used to determine a single tissue cell. Quantitative fluorescence PCR was performed using the total DNA as the template, and each sample was quantified using specific primers for mitochondrial genes and nuclear single-copy genes. The statistics using the formula for the PCR primers used to amplify each gene are shown in Table 1.
For the quantification of the mitochondrial DNA copy number, using the single-copy nuclear gene GCG as the reference gene, the multiple of the mitochondrial gene expression relative to GCG is the mitochondrial copy number of cells in the tissue. The calculation formula is as follows:
N = 2−Ctmt/2−Ctn
N: mtDNA copy number; Ctmt: Ct value for mitochondrial genes; Ctn: Ct value for nuclear single-copy genes.

2.8. Quantitative Real-Time PCR (qRT-PCR)

The total mRNA was extracted from 200 M2 stage oocytes and 50 blastocysts using an mRNA isolation kit (QIAGEN, Germany, 80284) according to the manufacturer’s instructions. The gene expressions were quantified using the CFX96 real-time system (Bio-Rad, Harkles, CA, USA). The internal control group was the expression level of GAPDH. The statistics for the formula for the PCR primers used to amplify each gene are shown in Table 2.

2.9. Western Blotting

A total of 200 M2 stage oocytes were collected, and the protein was extracted by RIPA (Beyotime, P0013 K); a 10–15% sodium dodecyl sulfate (SDS) separation gel and a concentration gel were prepared. The diluted primary antibodies H2AX (1:2000, 10856-1-AP, Proteintech, Rosemont, IL, USA) and p44/42 MAPK (1:1000, 9101, Cell Signaling) were added to the membrane and incubated overnight at 4 °C. The membranes were washed five times with TBST (10 min each time), supplemented with horseradish peroxidase-marked secondary antibody (1:5000; Proteintech, SA00001–1), oscillated, and then incubated at room temperature for 1 h. After incubation, each membrane was washed five times with TBST (10 min each time) and reacted with enhanced chemiluminescence solution (Tanon, 180–5001) at room temperature for 5 s, and the relative expressions of target proteins were measured using GAPDH (1:5000, 10494-1-AP, Proteintech) as the reference.

2.10. Assessment of Blastocyst Apoptosis

For the TUNEL (Beyotime, C1086S) assays, the blastocysts were incubated with 50 μL of TUNEL reaction mixture for 1 h at 37 °C in the dark. A fluorescence microscope connected to a digital camera was used to take pictures to capture the fluorescence signal. The images were processed and measured using NIH ImageJ software.

2.11. Statistics of Blastocyst Cell Proliferation

The propagation of blastocyst cells was cytochemically detected according to the manufacturer’s instructions (C0071L, Beyotime, China). Briefly, the blastocysts were incubated with the EdU staining buffer for 1 h, fixed with 4% polyformaldehyde, and stained for nuclei with Hoechst. The stained blastocysts were scanned and photographed under a microscope, and the numbers of positive cells were counted.

2.12. Statistical Analysis

All of the data were analyzed using SPSS software version 11.0 (IBM, Armonk, NY, USA). All of the experiments were performed more than 3 times. Comparisons of data between groups were performed with Student’s t-test. The values are expressed as the mean ± standard deviation, and significant differences are represented with * (p < 0.05), ** (p < 0.01), and *** (p < 0.001).

3. Results

3.1. Protective Effects of Sal at Different Concentrations on Porcine Oocytes

To determine the optimal concentration of Sal, different concentrations of Sal (0 μM, 50 μM, 250 μM, 400 μM) were added to the IVM culture medium. After 44 h of culture, the results showed that compared with the control group, Sal had the highest maturity rate at the concentration of 250 μM (Figure 1A,C 88.34 ± 4.32% vs. 88.83 ± 2.36% vs. 94.12 ± 2.29% vs. 89.71 ± 4.25%). The cleavage rate after 30 h showed statistically significant parthenogenetic activation, but there was no significant difference in the cleavage rate (Figure 1D 81.78 ± 5.18% vs. 86.40 ± 5.16% vs. 86.22 ± 6.65% vs. 84.76 ± 6.53%). The blastocyst rate was counted on the sixth day of parthenogenetic activation. The blastocyst rate was also the highest among oocytes under 250 μM Sal culture (Figure 1B,E 30.35 ± 3.20% vs. 38.89 ± 5.38% vs. 52.14 ± 7.32% vs. 28.58 ± 3.21%), and had the best protective effect on oocytes.
Based on the above results, a concentration of 250 μM was used in the follow-up experiment. Photographs of each COC were taken before and after in vitro culture, and the ratio between the final cumulus area and the initial cumulus area was calculated. The Sal treatment group significantly increased the area of cumulus expansion (Figure 2A,B). To investigate the reasons for the increase in cumulus expansion area, we collected digested cumulus cells for flow cytometry reactive oxygen species detection and mitochondrial DNA copy number detection, and found that the data in the treatment group were higher than those in the control group (Figure S1).

3.2. Effects of Sal Supplementation on the Levels of Oxidative Stress in Porcine Oocytes

Since Sal has free radical scavenging properties, we further evaluated whether Sal supplementation during IVM can improve the oxidative stress of porcine oocytes. As shown in Figure 3A,B, the ROS level in the porcine oocytes in the Sal group was significantly lower than that in the control group during the M2 stage, and Sal was not added during IVM. Based on these results, we further evaluated the level of GSH in porcine M2 oocytes, as shown in Figure 3C,D. Compared with the control group, the GSH level in the Sal-supplemented group was significantly higher.

3.3. Effects of Sal Supplementation on the Mitochondrial Function of Porcine Oocytes

Mitochondria are the energy factories of oocytes, one of the indicators of oocyte quality, and play an important role in cell metabolism, growth, and proliferation [17]. We used the JC-1 fluorescence reaction to evaluate the mitochondrial membrane potential (MMP) of the oocytes. Representative images of JC-1 staining are shown in Figure 4A. The quantitative results showed that the average relative value of fluorescence intensity (red/green) in the Sal-supplemented group was significantly higher than that in the control group (Figure 4B). We measured the concentration of ATP in oocytes between different treatment groups, and found that the ATP concentration in the treatment group treatment was significantly higher than that in the control group (Figure 4C). Some studies have suggested that the mitochondrial DNA (mtDNA) copy number could be used as a biomarker of human oocyte viability [18]. We measured that the mtDNA copy number in oocytes between different treatment groups was significantly higher than that in the control group (Figure 4D).

3.4. Effects of Sal Supplementation on Apoptosis and DNA Damage in Porcine Oocytes

Based on the mRNA expression, Sal significantly down-regulated the apoptosis related gene Caspase-3 (Figure 5A) and the mRNA expression of BAX/BCL-2 (Figure 5B), and significantly down-regulated the DNA breakage marker protein γH2AX (Figure 5C,D).

3.5. Effects of Sal Supplementation on MAPK Activation and Meiosis in Porcine Oocytes

The porcine COCs were cultured for 44 h in IVM media containing 250 μM Sal, after cumulus cells were removed from the COCs, the C-MOS, MEK, ERK1, and ERK2 mRNA expression levels in the oocytes were determined. We measured that the mRNA expressions in oocytes between different treatment groups were significantly higher than those in the control group (Figure 6C–F), and significantly increased the phosphorylated MAPK protein (Figure 6A,B). The mRNA expression of the oocyte maturation genes (CDK1, Cyclin B, and GFP-1) also increased significantly (Figure 6G).

3.6. The Addition of Sal Can Reduce the Apoptosis and Increase the Proliferation of PA Blastocysts

We analyzed the total cell numbers and the ability of blastocysts to proliferate on day 6. The analysis of the total blastocyst cell number showed that it was significantly increased in the Sal-supplemented group compared with the untreated group (Figure 7). The number of blastocyst proliferations in the treatment group was significantly higher than that in the untreated group (Figure 8A,B), and Sal significantly increased the expression of COX-2, which is involved in blastocyst formation, and the expression of the pluripotency genes NANOG, CDX2, SOX2, and OCT-4 (Figure 8C).
Using TUNEL staining for the blastocysts obtained on the sixth day after parthenogenetic activation of oocytes in the treatment group and the untreated group, the number of apoptotic cells was significantly lower than that in the untreated group (Figure 9A,B), and down-regulated the apoptosis-related gene Caspase-9 during the blastocyst stage (Figure 9C).

4. Discussion

Sal is a tyrosol-like glycoside that mainly exists in the roots of Rhodiola rosea plants, and has various biological and pharmacological properties. Numerous studies have been conducted over the past decade to investigate the medicinal properties of Sal, and anticancer, antioxidative, antiaging, antidiabetic, antidepressant, antihyperlipidemic, anti-inflammatory, and immunomodulatory effects were reported [19]. Although there have been studies indicating that Sal improves the lipid content in oocytes [20], we found that Sal promotes oocyte maturation while increasing mitochondrial activity, while reducing ROS and GSH levels in oocytes. This is reflected in aspects such as maturation, metabolism, cell communication, apoptosis, and oxidative stress. Our results provide new evidence for the improvement of oocyte quality and the subsequent effects of Sal.
To explore the impact of Sal on oocyte quality at a deeper level, considering the mechanism of oocytes and the in vivo physiology of oocyte maturation, the maturation of oocytes is closely related to the expansion of cumulus cells [21], cumulus cells are required for the transfer of energy or nutrients to support oocyte maturation. The highly active mitochondria in cumulus cells provide energy substrates for the maturation of oocytes [22], and have a critical role in protecting oocytes against oxidative stress [23]. The proliferative ability of cumulus cells is closely related to the nuclear and qualitative maturation of oocytes [24]. Sal promotes proliferation of vascular smooth muscle and PASMC by protecting mitochondria against oxidative stress [25,26]. Sal can reduce oxidative stress in human granulosa cell lines and reduce the occurrence of polycystic ovary syndrome [27]. Our results reveal the ability of Sal to promote the expansion of cumulus cells in terms of the energy supply to oocytes, which may be due to Sal reducing oxidative stress levels in cumulus cells and increasing mitochondrial DNA copy numbers.
Cumulus cell expansion is considered to be an important marker of oocyte maturation [28]. MPF consists of p-cdk1 and Cyclin B1, and is the main promoter of meiosis, which is essential for IVM in mammalian oocytes [29]. The activation of MPF and ERK1/2 requires the activation of maternal Ccnb1 and MOS mRNA translation [30], respectively. Taken together, the cooperation and positive feedback active action of ERK1/2 and CDK1 lead to the fine-tuning of mRNA translation and cell cycle progression during mouse oocyte maturation. MAPK plays a key role in promoting and stabilizing the spindle pole during oocyte meiosis [31], and the formation of the spindle structure is essential for chromosome segregation and cytokinesis [32]. Related studies have shown that in porcine oocytes, MAPK is mainly located at the poles of the metaphase spindle, and treatment with U0126 inhibits MAPK activity, resulting in the inhibition of chromosome segregation, PB1 discharge, and MII spindle formation [33]. The activation of MAPK plays an important role in oocyte maturation. Additionally, in most mammalian oocytes, GFP plays an important role in granulosa cell development and oocyte fertilization [34]. Sal can protect human bone marrow-derived endothelial progenitor cells [35], PC-12 cells [36], and alveolar epithelial cells through the activation of the ERK1/2 and MAPK signaling pathways [37]. The results indicate that Sal can increase the mRNA expression of the MAPK pathway (C-MOS, MEK, and ERK1/2) and that MAPK phosphorylation significantly increases, enhancing oocyte maturation by increasing the expressions of genes (CDK1, CyclinB, and GFP-1) related to oocyte maturation. This also suggests the potential mechanism by which Sal promotes oocyte maturation, which may be through activating the MAPK signaling pathway and maintaining spindle stability; further research is needed. This also explains the significantly higher exclusion rate of the first polar body in the treatment group.
Nevertheless, more studies are needed to further explore the mechanisms affecting maturity. There are many factors that affect the development of oocytes in vitro, among which oxidative stress is an important factor leading to oocyte damage [38]. Pig oocytes have a higher lipid content than other animals, and are particularly susceptible to oxidative stress [39], and GSH is an antioxidant that can scavenge ROS [40]. Particularly important in maintaining the redox state of the oocyte, a loss of GSH can lead to oxidative stress and the apoptosis of germ cells [41]. In related studies, Sal can increase the level of GSH and reduce the level of ROS in human umbilical vein endothelial cells (HUVECs) [42] and human RPE cells [43], and then reduce cell apoptosis to protect cells. In the present study, the addition of Sal during IVM reduced the accumulation of ROS in oocytes and increased the accumulation of GSH. We speculate that Sal may reduce oxidative stress by removing intracellular ROS and increasing GSH synthesis, thereby increasing the quality of porcine oocytes.
Mitochondria play an important role in the function of mammalian oocytes [44,45]. Mitochondria regulate the mitochondrial membrane potential through ATP [46]. Mitochondrial dysfunction and reduced mitochondrial membrane potential are the causes of poor oocyte quality and early embryo dysfunction [47]. That is, an abnormality of MMP is closely related to fertilization, germ cell development, and apoptosis [48]. Mitochondria synthesize adenosine triphosphate (ATP) via β-oxidation, a process that involves the electron transport chain [49]. During the meiotic maturation of oocytes, mitochondrial integrity is considered to be one of the indicators of cytoplasmic maturation [50]. Due to the complete maternal inheritance of mitochondria, mtDNA in oocytes is the only source of mtDNA in embryos [51], and numerous studies have shown a positive correlation between the mtDNA copy number and oocyte quality [18]. Numerous studies have shown that Sal can protect various cells, such as PC12 cells [52], HT22 cells [53], and 2BS cells [54], by regulating mitochondrial function and ROS levels. After treatment of diabetic mice with Sal, mitochondrial DNA copies and electron transfer chain proteins in the kidneys of mice significantly increased [55]. In our study, it was further confirmed that the MMP and mtDNA copy numbers of the treatment group significantly increased, and the ATP content significantly increased, which was also verified by previous experiments. The effect of Sal on promoting the maturation of oocytes may be due to the protection of mitochondria by Sal.
BCL2 family proteins, BCL2 and BAX, modulate mitochondrial membrane potential and activation of caspases [56]. In the mitochondrial apoptosis pathway, BCL2 has an anti-apoptotic role, whereas BAX promotes apoptosis following mitochondrial damage [57]. The protective effect of Sal on mitochondrial membrane potential and ATP production has been described above, and Sal inhibited cancer cell activation by inhibiting BCL2 in nasopharyngeal carcinoma cells [58] and human hepatocellular carcinoma [59]. Therefore, the expression levels of mitochondrial genes BAX and BCL2 were analyzed. In our experiments we found via Q-PCR that Sal inhibited BAX/BCL-2. In further experiments, the expression of the Caspase-3 gene and the expression of γH2AX protein were significantly reduced. This further illustrates that Sal protects against embryonic apoptosis and DNA damage based on mitochondria.
Oocyte quality is a key factor in determining embryo development [60]. Therefore, our study shows the treatment group after PA increases the developmental potential of the blastocysts. COX2 affects the embryonic implantation ability during embryonic development [61]. In our results, SAL increased the expression of COX-2 in blastocysts and the expression of totipotency-related genes (OCT-4, CDX2, SOX2, and NANOG) [62]. After EdU staining and TUNEL staining, the proliferation of PA blastocyst cells in the treatment group increased significantly, decreased apoptotic cells significantly, and the expression of the apoptosis gene Caspase-9 slowed down the occurrence of apoptosis during embryonic development. This also further verified the positive effects of Sal on the quality and maturation of oocytes.

5. Conclusions

These results indicate that Sal modifies the expressions of key genes involved in oocyte cytoplasmic development and maturation, enhances their developmental ability, and is involved in modifying oocyte maturation, mitochondrial metabolism, apoptosis, and oxidative stress levels; these effects improve embryonic development and quality, and increase embryo yield, and support an optimized plan for efficient IVP embryo production.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/genes14091729/s1, Figure S1: Analysis of ROS levels and mitochondrial DNA copy number in cumulus cells.

Author Contributions

Conceptualization, M.Z. and Y.J.; validation, S.S. and Z.G.; formal analysis, B.H. and L.L; investigation, Z.C. and L.Q.; resources, M.Z., Y.J. and X.Y.; data curation, S.S.; writing—original draft preparation, S.S., Z.G. and X.Y.; writing—review and editing, X.Y.; visualization, L.L.; supervision, M.Z. and Y.J.; project administration, M.Z. and Y.J.; funding acquisition, M.Z. and X.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the earmarked fund for the Jilin Provincial Natural Science Foundation of China (20210101014JC), and an international cooperation project (3D5205987203).

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yoshioka, K. Development and application of a chemically defined medium for the in vitro production of porcine embryos. J. Reprod. Dev. 2011, 57, 9–16. [Google Scholar] [CrossRef]
  2. Sekhar, R.V.; Patel, S.G.; Guthikonda, A.P.; Reid, M.; Balasubramanyam, A.; Taffet, G.E.; Jahoor, F. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am. J. Clin. Nutr. 2011, 94, 847–853. [Google Scholar] [CrossRef] [PubMed]
  3. Brussow, K.P.; Torner, H.; Kanitz, W.; Ratky, J. In vitro technologies related to pig embryo transfer. Reprod. Nutr. Dev. 2000, 40, 469–480. [Google Scholar] [CrossRef] [PubMed]
  4. Day, B.N. Reproductive biotechnologies: Current status in porcine reproduction. Anim. Reprod. Sci. 2000, 60, 161–172. [Google Scholar] [CrossRef] [PubMed]
  5. Tatemoto, H.; Muto, N. Mitogen-activated protein kinase regulates normal transition from metaphase to interphase following parthenogenetic activation in porcine oocytes. Zygote 2001, 9, 15–23. [Google Scholar] [CrossRef] [PubMed]
  6. Hu, W.; Zhang, Y.; Wang, D.; Yang, T.; Qi, J.; Zhang, Y.; Jiang, H.; Zhang, J.; Sun, B.; Liang, S. Iron Overload-Induced Ferroptosis Impairs Porcine Oocyte Maturation and Subsequent Embryonic Developmental Competence in vitro. Front. Cell Dev. Biol. 2021, 9, 673291. [Google Scholar] [CrossRef]
  7. Chatzispyrou, I.A.; Alders, M.; Guerrero-Castillo, S.; Zapata Perez, R.; Haagmans, M.A.; Mouchiroud, L.; Koster, J.; Ofman, R.; Baas, F.; Waterham, H.R.; et al. A homozygous missense mutation in ERAL1, encoding a mitochondrial rRNA chaperone, causes Perrault syndrome. Hum. Mol. Genet. 2017, 26, 2541–2550. [Google Scholar] [CrossRef] [PubMed]
  8. van der Reest, J.; Nardini Cecchino, G.; Haigis, M.C.; Kordowitzki, P. Mitochondria: Their relevance during oocyte ageing. Ageing Res. Rev. 2021, 70, 101378. [Google Scholar] [CrossRef] [PubMed]
  9. Guo, B.; Dong, W.; Huo, J.; Sun, G.; Qin, Z.; Liu, X.; Zhang, B.; Wang, W. Integrated Metabolomics and Network Pharmacology Analysis Immunomodulatory Mechanisms of Qifenggubiao Granules. Front. Pharmacol. 2022, 13, 828175. [Google Scholar] [CrossRef]
  10. Yu, H.; Lin, Y.; Zhong, Y.; Guo, X.; Lin, Y.; Yang, S.; Liu, J.; Xie, X.; Sun, Y.; Wang, D.; et al. Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease. Respir. Res. 2022, 23, 70. [Google Scholar] [CrossRef]
  11. Chiang, H.M.; Chen, H.C.; Wu, C.S.; Wu, P.Y.; Wen, K.C. Rhodiola plants: Chemistry and biological activity. J. Food Drug Anal. 2015, 23, 359–369. [Google Scholar] [CrossRef] [PubMed]
  12. Wang, J.; Li, J.Z.; Lu, A.X.; Zhang, K.F.; Li, B.J. Anticancer effect of Sal on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression. Oncol. Lett. 2014, 7, 1159–1164. [Google Scholar] [CrossRef] [PubMed]
  13. Li, F.; Tang, H.; Xiao, F.; Gong, J.; Peng, Y.; Meng, X. Protective effect of Sal from Rhodiolae Radix on diabetes-induced oxidative stress in mice. Molecules 2011, 16, 9912–9924. [Google Scholar] [CrossRef] [PubMed]
  14. Recio, M.C.; Giner, R.M.; Manez, S. Immunmodulatory and Antiproliferative Properties of Rhodiola Species. Planta Med. 2016, 82, 952–960. [Google Scholar] [CrossRef] [PubMed]
  15. Fu, S.; Yan, M.; Fan, Q.; Xu, J. Sal promotes osteoblast proliferation and differentiation via the activation of AMPK to inhibit bone resorption of knee osteoarthritis mice. Tissue Cell 2022, 79, 101917. [Google Scholar] [CrossRef] [PubMed]
  16. Ying, Y.; Luo, J. Sal promotes human periodontal ligament cell proliferation and osteocalcin secretion via ERK1/2 and PI3K/Akt signaling pathways. Exp. Ther. Med. 2018, 15, 5041–5045. [Google Scholar] [CrossRef] [PubMed]
  17. Wang, N.; Zhang, C.; Chen, M.; Shi, Z.; Zhou, Y.; Shi, X.; Zhou, W.; Zhu, Z. Characterization of MicroRNAs Associated with Reproduction in the Brown Planthopper, Nilaparvata lugens. Int. J. Mol. Sci. 2022, 23, 7808. [Google Scholar] [CrossRef]
  18. Cecchino, G.N.; Garcia-Velasco, J.A. Mitochondrial DNA copy number as a predictor of embryo viability. Fertil. Steril. 2019, 111, 205–211. [Google Scholar] [CrossRef]
  19. Zhang, X.; Xie, L.; Long, J.; Xie, Q.; Zheng, Y.; Liu, K.; Li, X. Sal: A review of its recent advances in synthetic pathways and pharmacological properties. Chem. Biol. Interact. 2021, 339, 109268. [Google Scholar] [CrossRef]
  20. Li, J.; Wang, R.; Chen, Q.; Tian, Y.; Gao, L.; Lei, A. Sal improves porcine oocyte maturation and subsequent embryonic development by promoting lipid metabolism. Theriogenology 2022, 192, 89–96. [Google Scholar] [CrossRef]
  21. Lee, S.; Kang, H.G.; Jeong, P.S.; Nanjidsuren, T.; Song, B.S.; Jin, Y.B.; Lee, S.R.; Kim, S.U.; Sim, B.W. Effect of Oocyte Quality Assessed by Brilliant Cresyl Blue (BCB) Staining on Cumulus Cell Expansion and Sonic Hedgehog Signaling in Porcine during In Vitro Maturation. Int. J. Mol. Sci. 2020, 21, 4423. [Google Scholar] [CrossRef] [PubMed]
  22. Sreerangaraja Urs, D.B.; Wu, W.H.; Komrskova, K.; Postlerova, P.; Lin, Y.F.; Tzeng, C.R.; Kao, S.H. Mitochondrial Function in Modulating Human Granulosa Cell Steroidogenesis and Female Fertility. Int. J. Mol. Sci. 2020, 21, 3592. [Google Scholar] [CrossRef] [PubMed]
  23. Tatemoto, H.; Sakurai, N.; Muto, N. Protection of porcine oocytes against apoptotic cell death caused by oxidative stress during In vitro maturation: Role of cumulus cells. Biol. Reprod. 2000, 63, 805–810. [Google Scholar] [CrossRef] [PubMed]
  24. Okazaki, T.; Nishibori, M.; Yamashita, Y.; Shimada, M. LH reduces proliferative activity of cumulus cells and accelerates GVBD of porcine oocytes. Mol. Cell Endocrinol. 2003, 209, 43–50. [Google Scholar] [CrossRef]
  25. Zhuang, X.; Maimaitijiang, A.; Li, Y.; Shi, H.; Jiang, X. Sal inhibits high-glucose induced proliferation of vascular smooth muscle cells via inhibiting mitochondrial fission and oxidative stress. Exp. Ther. Med. 2017, 14, 515–524. [Google Scholar] [CrossRef]
  26. Huang, X.; Zou, L.; Yu, X.; Chen, M.; Guo, R.; Cai, H.; Yao, D.; Xu, X.; Chen, Y.; Ding, C.; et al. Sal attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway. J. Mol. Cell Cardiol. 2015, 82, 153–166. [Google Scholar] [CrossRef]
  27. Ji, R.; Jia, F.Y.; Chen, X.; Wang, Z.H.; Jin, W.Y.; Yang, J. Sal alleviates oxidative stress and apoptosis via AMPK/Nrf2 pathway in DHT-induced human granulosa cell line KGN. Arch. Biochem. Biophys. 2022, 715, 109094. [Google Scholar] [CrossRef]
  28. Chen, L.; Wert, S.E.; Hendrix, E.M.; Russell, P.T.; Cannon, M.; Larsen, W.J. Hyaluronic acid synthesis and gap junction endocytosis are necessary for normal expansion of the cumulus mass. Mol. Reprod. Dev. 1990, 26, 236–247. [Google Scholar] [CrossRef]
  29. Guo, M.; Cao, Y.; Wang, T.; Song, X.; Liu, Z.; Zhou, E.; Deng, X.; Zhang, N.; Yang, Z. Baicalin inhibits Staphylococcus aureus-induced apoptosis by regulating TLR2 and TLR2-related apoptotic factors in the mouse mammary glands. Eur. J. Pharmacol. 2014, 723, 481–488. [Google Scholar] [CrossRef]
  30. Kalous, J.; Tetkova, A.; Kubelka, M.; Susor, A. Importance of ERK1/2 in Regulation of Protein Translation during Oocyte Meiosis. Int. J. Mol. Sci. 2018, 19, 698. [Google Scholar] [CrossRef]
  31. Wang, F.; Zhang, L.; Duan, X.; Zhang, G.L.; Wang, Z.B.; Wang, Q.; Xiong, B.; Sun, S.C. RhoA-mediated FMNL1 regulates GM130 for actin assembly and phosphorylates MAPK for spindle formation in mouse oocyte meiosis. Cell Cycle 2015, 14, 2835–2843. [Google Scholar] [CrossRef] [PubMed]
  32. Li, J.; Ha, S.; Li, Z.; Huang, Y.; Lin, E.; Xiao, W. Aurora B prevents aneuploidy via MAD2 during the first mitotic cleavage in oxidatively damaged embryos. Cell Prolif. 2019, 52, e12657. [Google Scholar] [CrossRef] [PubMed]
  33. Huo, L.J.; Fan, H.Y.; Liang, C.G.; Yu, L.Z.; Zhong, Z.S.; Chen, D.Y.; Sun, Q.Y. Regulation of ubiquitin-proteasome pathway on pig oocyte meiotic maturation and fertilization. Biol. Reprod. 2004, 71, 853–862. [Google Scholar] [CrossRef] [PubMed]
  34. Hsieh, M.; Lee, D.; Panigone, S.; Horner, K.; Chen, R.; Theologis, A.; Lee, D.C.; Threadgill, D.W.; Conti, M. Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol. Cell Biol. 2007, 27, 1914–1924. [Google Scholar] [CrossRef]
  35. Tang, Y.; Vater, C.; Jacobi, A.; Liebers, C.; Zou, X.; Stiehler, M. Sal exerts angiogenic and cytoprotective effects on human bone marrow-derived endothelial progenitor cells via Akt/mTOR/p70S6K and MAPK signalling pathways. Br. J. Pharmacol. 2014, 171, 2440–2456. [Google Scholar] [CrossRef]
  36. Liao, Z.L.; Su, H.; Tan, Y.F.; Qiu, Y.J.; Zhu, J.P.; Chen, Y.; Lin, S.S.; Wu, M.H.; Mao, Y.P.; Hu, J.J.; et al. Sal protects PC-12 cells against amyloid beta-induced apoptosis by activation of the ERK1/2 and AKT signaling pathways. Int. J. Mol. Med. 2019, 43, 1769–1777. [Google Scholar] [CrossRef]
  37. Guo, B.; Zuo, Z.; Di, X.; Huang, Y.; Gong, G.; Xu, B.; Wang, L.; Zhang, X.; Liang, Z.; Hou, Y.; et al. Sal attenuates HALI via IL-17A-mediated ferroptosis of alveolar epithelial cells by regulating Act1-TRAF6-p38 MAPK pathway. Cell Commun. Signal 2022, 20, 183. [Google Scholar] [CrossRef]
  38. Orsi, N.M.; Leese, H.J. Protection against reactive oxygen species during mouse preimplantation embryo development: Role of EDTA, oxygen tension, catalase, superoxide dismutase and pyruvate. Mol. Reprod. Dev. 2001, 59, 44–53. [Google Scholar] [CrossRef]
  39. Dunning, K.R.; Russell, D.L.; Robker, R.L. Lipids and oocyte developmental competence: The role of fatty acids and beta-oxidation. Reproduction 2014, 148, R15–R27. [Google Scholar] [CrossRef]
  40. Gasparrini, B.; Boccia, L.; Marchandise, J.; Di Palo, R.; George, F.; Donnay, I.; Zicarelli, L. Enrichment of in vitro maturation medium for buffalo (Bubalus bubalis) oocytes with thiol compounds: Effects of cystine on glutathione synthesis and embryo development. Theriogenology 2006, 65, 275–287. [Google Scholar] [CrossRef]
  41. Lim, J.; Luderer, U. Glutathione deficiency sensitizes cultured embryonic mouse ovaries to benzo[a]pyrene-induced germ cell apoptosis. Toxicol. Appl. Pharmacol. 2018, 352, 38–45. [Google Scholar] [CrossRef] [PubMed]
  42. Hu, R.; Wang, M.Q.; Ni, S.H.; Wang, M.; Liu, L.Y.; You, H.Y.; Wu, X.H.; Wang, Y.J.; Lu, L.; Wei, L.B. Sal ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-kappaB/NLRP3 signaling pathway in AGEs-induced HUVECs. Eur. J. Pharmacol. 2020, 867, 172797. [Google Scholar] [CrossRef] [PubMed]
  43. Yin, Y.; Liu, D.; Tian, D. Sal prevents hydroperoxide-induced oxidative stress and apoptosis in retinal pigment epithelium cells. Exp. Ther. Med. 2018, 16, 2363–2368. [Google Scholar] [CrossRef] [PubMed]
  44. Ramalho-Santos, J.; Varum, S.; Amaral, S.; Mota, P.C.; Sousa, A.P.; Amaral, A. Mitochondrial functionality in reproduction: From gonads and gametes to embryos and embryonic stem cells. Hum. Reprod. Update 2009, 15, 553–572. [Google Scholar] [CrossRef]
  45. May-Panloup, P.; Chretien, M.F.; Malthiery, Y.; Reynier, P. Mitochondrial DNA in the oocyte and the developing embryo. Curr. Top. Dev. Biol. 2007, 77, 51–83. [Google Scholar] [CrossRef]
  46. Yao, X.; Jiang, H.; Liang, S.; Shen, X.; Gao, Q.; Xu, Y.N.; Kim, N.H. Laminarin enhances the quality of aged pig oocytes by reducing oxidative stress. J. Reprod. Dev. 2018, 64, 489–494. [Google Scholar] [CrossRef]
  47. Liang, S.; Jin, Y.X.; Yuan, B.; Zhang, J.B.; Kim, N.H. Melatonin enhances the developmental competence of porcine somatic cell nuclear transfer embryos by preventing DNA damage induced by oxidative stress. Sci. Rep. 2017, 7, 11114. [Google Scholar] [CrossRef]
  48. Bisht, S.; Dada, R. Oxidative stress: Major executioner in disease pathology, role in sperm DNA damage and preventive strategies. Front. Biosci. Sch. 2017, 9, 420–447. [Google Scholar] [CrossRef]
  49. Chen, W.; Sun, Y.; Sun, Q.; Zhang, J.; Jiang, M.; Chang, C.; Huang, X.; Wang, C.; Wang, P.; Zhang, Z.; et al. MFN2 Plays a Distinct Role from MFN1 in Regulating Spermatogonial Differentiation. Stem Cell Rep. 2020, 14, 803–817. [Google Scholar] [CrossRef]
  50. Zhang, Y.; ShiYang, X.; Zhang, Y.; Li, Y.; Shi, X.; Xiong, B. Exposure to aristolochic acid I compromises the maturational competency of porcine oocytes via oxidative stress-induced DNA damage. Aging 2019, 11, 2241–2252. [Google Scholar] [CrossRef]
  51. Singh, I.; Parte, P. Heterogeneity in the Epigenetic Landscape of Murine Testis-Specific Histone Variants TH2A and TH2B Sharing the Same Bi-Directional Promoter. Front. Cell Dev. Biol. 2021, 9, 755751. [Google Scholar] [CrossRef]
  52. Tang, Y.; Hou, Y.; Zeng, Y.; Hu, Y.; Zhang, Y.; Wang, X.; Meng, X. Sal attenuates CoCl2-simulated hypoxia injury in PC12 cells partly by mitochondrial protection. Eur. J. Pharmacol. 2021, 912, 174617. [Google Scholar] [CrossRef]
  53. Wang, X.; Tang, Y.; Xie, N.; Bai, J.; Jiang, S.; Zhang, Y.; Hou, Y.; Meng, X. Sal, a phenyl ethanol glycoside from Rhodiola crenulata, orchestrates hypoxic mitochondrial dynamics homeostasis by stimulating Sirt1/p53/Drp1 signaling. J. Ethnopharmacol. 2022, 293, 115278. [Google Scholar] [CrossRef]
  54. Mao, G.X.; Xu, X.G.; Wang, S.Y.; Li, H.F.; Zhang, J.; Zhang, Z.S.; Su, H.L.; Chen, S.S.; Xing, W.M.; Wang, Y.Z.; et al. Sal Delays Cellular Senescence by Stimulating Mitochondrial Biogenesis Partly through a miR-22/SIRT-1 Pathway. Oxid. Med. Cell Longev. 2019, 2019, 5276096. [Google Scholar] [CrossRef]
  55. Xue, H.; Li, P.; Luo, Y.; Wu, C.; Liu, Y.; Qin, X.; Huang, X.; Sun, C. Sal stimulates the Sirt1/PGC-1alpha axis and ameliorates diabetic nephropathy in mice. Phytomedicine 2019, 54, 240–247. [Google Scholar] [CrossRef]
  56. Daniel, L.L.; Daniels, C.R.; Harirforoosh, S.; Foster, C.R.; Singh, M.; Singh, K. Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction. J. Am. Heart Assoc. 2014, 3, e001286. [Google Scholar] [CrossRef]
  57. Miranda, M.A.; Marcato, P.D.; Mondal, A.; Chowdhury, N.; Gebeyehu, A.; Surapaneni, S.K.; Bentley, M.; Amaral, R.; Pan, C.X.; Singh, M. Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells. Mater. Sci. Eng. C Mater. Biol. Appl. 2021, 119, 111460. [Google Scholar] [CrossRef]
  58. Liu, S.; Li, Y.; Li, Z. Sal suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis. Cell Cycle 2022, 21, 720–729. [Google Scholar] [CrossRef]
  59. Ding, S.Y.; Wang, M.T.; Dai, D.F.; Peng, J.L.; Wu, W.L. Sal induces apoptosis and triggers endoplasmic reticulum stress in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 2020, 527, 1057–1063. [Google Scholar] [CrossRef]
  60. Marteil, G.; Richard-Parpaillon, L.; Kubiak, J.Z. Role of oocyte quality in meiotic maturation and embryonic development. Reprod. Biol. 2009, 9, 203–224. [Google Scholar] [CrossRef]
  61. Pakrasi, P.L.; Jain, A.K. Cyclooxygenase-2-derived endogenous prostacyclin reduces apoptosis and enhances embryo viability in mouse. Prostaglandins Leukot. Essent. Fatty Acids 2008, 79, 27–33. [Google Scholar] [CrossRef] [PubMed]
  62. Rizzino, A.; Wuebben, E.L. Sox2/Oct4: A delicately balanced partnership in pluripotent stem cells and embryogenesis. Biochim. Biophys. Acta 2016, 1859, 780–791. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Protective effects of Sal at different concentrations on porcine oocytes. (A) Representative images of oocyte PBE in the control and Sal groups. The black arrow indicates an oocyte with the first polar body. Scale bar = 100 μm. (B) Representative images of embryo development on day 6 in the control and Sal groups. Scale bar = 200 μm. (C) Maturation rate of oocytes in the control (n = 292) and Sal groups (50 μM n = 301; 250 μM n = 296; 400 μM n = 294). (D) Cleavage rates of porcine parthenogenetic embryos at 30 h after parthenogenetic activation in the control (n = 281) and Sal groups (50 μM n = 286; 250 μM n = 272; 400 μM n = 278). (E) Blastocyst formation rates of porcine parthenogenetic embryos on day 6 in the control (n = 281) and Sal groups (50 μM n = 286; 250 μM n = 272; 400 μM n = 278). The data were obtained from three separate experiments. Values are expressed as the mean ± standard deviation, and significant differences are represented with * (p < 0.05) and *** (p < 0.001).
Figure 1. Protective effects of Sal at different concentrations on porcine oocytes. (A) Representative images of oocyte PBE in the control and Sal groups. The black arrow indicates an oocyte with the first polar body. Scale bar = 100 μm. (B) Representative images of embryo development on day 6 in the control and Sal groups. Scale bar = 200 μm. (C) Maturation rate of oocytes in the control (n = 292) and Sal groups (50 μM n = 301; 250 μM n = 296; 400 μM n = 294). (D) Cleavage rates of porcine parthenogenetic embryos at 30 h after parthenogenetic activation in the control (n = 281) and Sal groups (50 μM n = 286; 250 μM n = 272; 400 μM n = 278). (E) Blastocyst formation rates of porcine parthenogenetic embryos on day 6 in the control (n = 281) and Sal groups (50 μM n = 286; 250 μM n = 272; 400 μM n = 278). The data were obtained from three separate experiments. Values are expressed as the mean ± standard deviation, and significant differences are represented with * (p < 0.05) and *** (p < 0.001).
Genes 14 01729 g001
Figure 2. Protective effects of Sal at different concentrations on porcine oocytes. (A) Representative images of cumulus cell expansion status before and after IVM in the control and Sal groups. Scale bar = 100 μm. (B) Relative cumulus cell expansion areas in the control (n = 31) and Sal groups (n = 33). The data were obtained from three separate experiments. Significant differences are represented with ** (p < 0.01).
Figure 2. Protective effects of Sal at different concentrations on porcine oocytes. (A) Representative images of cumulus cell expansion status before and after IVM in the control and Sal groups. Scale bar = 100 μm. (B) Relative cumulus cell expansion areas in the control (n = 31) and Sal groups (n = 33). The data were obtained from three separate experiments. Significant differences are represented with ** (p < 0.01).
Genes 14 01729 g002
Figure 3. Effects of Sal supplementation on the levels of oxidative stress in porcine oocytes. (A) Representative fluorescence images of intracellular H2DCFDA (ROS) levels in the control and Sal groups. Scale bar = 100 μm. (B) Representative fluorescence images of intracellular glutathione (ROS) levels in the control (n = 62) and Sal groups (n = 59). Scale bar = 100 μm. (C) Relative intracellular GSH levels in the control and Sal groups. (D) Relative intracellular GSH levels in the control (n = 53) and Sal groups (n = 54). Significant differences are represented with ** (p < 0.01) and *** (p < 0.001). The data were obtained from three separate experiments.
Figure 3. Effects of Sal supplementation on the levels of oxidative stress in porcine oocytes. (A) Representative fluorescence images of intracellular H2DCFDA (ROS) levels in the control and Sal groups. Scale bar = 100 μm. (B) Representative fluorescence images of intracellular glutathione (ROS) levels in the control (n = 62) and Sal groups (n = 59). Scale bar = 100 μm. (C) Relative intracellular GSH levels in the control and Sal groups. (D) Relative intracellular GSH levels in the control (n = 53) and Sal groups (n = 54). Significant differences are represented with ** (p < 0.01) and *** (p < 0.001). The data were obtained from three separate experiments.
Genes 14 01729 g003
Figure 4. Effects of Sal supplementation on the mitochondrial function of porcine oocytes. (A) Representative fluorescence images of JC-1 fluorescence staining in the control and Sal groups. Scale bar = 100 μm. (B) Relative intracellular MMP levels in the control (n = 40) and Sal groups (n = 36). (C) Relative ATP levels in the control and Sal groups. (D) Mitochondrial DNA copy numbers in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with ** (p < 0.01) and *** (p < 0.001).
Figure 4. Effects of Sal supplementation on the mitochondrial function of porcine oocytes. (A) Representative fluorescence images of JC-1 fluorescence staining in the control and Sal groups. Scale bar = 100 μm. (B) Relative intracellular MMP levels in the control (n = 40) and Sal groups (n = 36). (C) Relative ATP levels in the control and Sal groups. (D) Mitochondrial DNA copy numbers in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with ** (p < 0.01) and *** (p < 0.001).
Genes 14 01729 g004
Figure 5. Effects of Sal supplementation on apoptosis and DNA damage in porcine oocytes. (A) Relative gene expressions of Caspase-3 in the control and Sal groups. (B) Relative gene expressions of BAX/BCL-2 in the control and Sal groups. (C) The protein expression levels of γH2AX in the control and Sal groups. (D) Relative levels of γH2AX in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with * (p < 0.05), and ** (p < 0.01).
Figure 5. Effects of Sal supplementation on apoptosis and DNA damage in porcine oocytes. (A) Relative gene expressions of Caspase-3 in the control and Sal groups. (B) Relative gene expressions of BAX/BCL-2 in the control and Sal groups. (C) The protein expression levels of γH2AX in the control and Sal groups. (D) Relative levels of γH2AX in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with * (p < 0.05), and ** (p < 0.01).
Genes 14 01729 g005
Figure 6. Effects of Sal supplementation on MAPK activation and meiosis of porcine oocytes. (A) The protein expression levels of p-MAPK in the control and Sal groups. (B) Relative levels of p-MAPK in the control and Sal groups. (C) Relative gene expressions of ERK1 in the control and Sal groups. (D) Relative gene expressions of ERK2 in the control and Sal groups. (E) Relative gene expressions of MEK in the control and Sal groups. (F) Relative gene expressions of C-MOS in the control and Sal groups. (G) Relative gene expressions of GDF-9, CDK-1, and Cyclin B in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with * (p < 0.05), ** (p < 0.01), and *** (p < 0.001).
Figure 6. Effects of Sal supplementation on MAPK activation and meiosis of porcine oocytes. (A) The protein expression levels of p-MAPK in the control and Sal groups. (B) Relative levels of p-MAPK in the control and Sal groups. (C) Relative gene expressions of ERK1 in the control and Sal groups. (D) Relative gene expressions of ERK2 in the control and Sal groups. (E) Relative gene expressions of MEK in the control and Sal groups. (F) Relative gene expressions of C-MOS in the control and Sal groups. (G) Relative gene expressions of GDF-9, CDK-1, and Cyclin B in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with * (p < 0.05), ** (p < 0.01), and *** (p < 0.001).
Genes 14 01729 g006
Figure 7. The addition of Sal can reduce the apoptosis of PA blastocysts and increase the proliferation of PA blastocysts. (A) Hoechst 33,342 staining of blastocysts on day 7 in the control and Sal groups. Scale bar = 50 μm. (B) Blastocyst total cell numbers in the control (n = 43) and Sal groups (n = 40). The data were obtained from three separate experiments. Significant differences are represented with ** (p < 0.01).
Figure 7. The addition of Sal can reduce the apoptosis of PA blastocysts and increase the proliferation of PA blastocysts. (A) Hoechst 33,342 staining of blastocysts on day 7 in the control and Sal groups. Scale bar = 50 μm. (B) Blastocyst total cell numbers in the control (n = 43) and Sal groups (n = 40). The data were obtained from three separate experiments. Significant differences are represented with ** (p < 0.01).
Genes 14 01729 g007
Figure 8. The addition of Sal can reduce the apoptosis of PA blastocysts and increase the proliferation of PA blastocysts. (A) Staining of EDU in blastocysts. Scale bar = 50 μm. (B) Rates of cell proliferation in blastocysts developing in the control (n = 61) and Sal groups (n = 67). (C) Relative gene expressions of COX-2, NANOG, CDX2, SOX2, and OCT-4 at blastocyst stage in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with * (p < 0.05) and ** (p < 0.01).
Figure 8. The addition of Sal can reduce the apoptosis of PA blastocysts and increase the proliferation of PA blastocysts. (A) Staining of EDU in blastocysts. Scale bar = 50 μm. (B) Rates of cell proliferation in blastocysts developing in the control (n = 61) and Sal groups (n = 67). (C) Relative gene expressions of COX-2, NANOG, CDX2, SOX2, and OCT-4 at blastocyst stage in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with * (p < 0.05) and ** (p < 0.01).
Genes 14 01729 g008
Figure 9. The addition of Sal can reduce the apoptosis of PA blastocysts and increase the proliferation of PA blastocysts. (A) Staining of TUNEL in blastocysts. Scale bar = 50 μm. (B) Rates of cell apoptosis in developing blastocysts in the control (n = 23) and Sal groups (n = 20). (C) Relative gene expressions of Caspase-9 at the blastocyst stage in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with * (p < 0.05) and ** (p < 0.01).
Figure 9. The addition of Sal can reduce the apoptosis of PA blastocysts and increase the proliferation of PA blastocysts. (A) Staining of TUNEL in blastocysts. Scale bar = 50 μm. (B) Rates of cell apoptosis in developing blastocysts in the control (n = 23) and Sal groups (n = 20). (C) Relative gene expressions of Caspase-9 at the blastocyst stage in the control and Sal groups. The data were obtained from three separate experiments. Significant differences are represented with * (p < 0.05) and ** (p < 0.01).
Genes 14 01729 g009
Table 1. Primer sequences of Mitochondrial DNA copy number in porcine oocyte for RT-PCR.
Table 1. Primer sequences of Mitochondrial DNA copy number in porcine oocyte for RT-PCR.
Gene NameSequenceAmplicon Size (bp)Accession Number
ATF6F: TATTTGCCTCTTTCATTGCCC
R: GGATCGAGATTGTGCGGTTAT
123NC_000845.1
ND1F: GCCACATCCTCAATCTCCAT
R: GATTAGAGGGTAGGGTATTGGTAG
99NC_000845.1
COX1F: TCCAATGGACATTATGGCTC
R: GAAGACATCTCGGCTGAACT
220NC_010443.5
GCGF: GAATCAACACCATCGGTCAAAT
R: CTCCACCCATAGAATGCCCAGT
198NC_010457.5
GADPHF: CCCAGAATATCATCCCTGCT
R: CTGCTTCACCACCTTCTTGA
185NC_010447.5
F, forward; R, reverse.
Table 2. The names of the tested genes, sequences of primers, sizes of PCR products, and accession numbers for RT-qPCR experiments.
Table 2. The names of the tested genes, sequences of primers, sizes of PCR products, and accession numbers for RT-qPCR experiments.
Gene NameSequenceAmplicon Size (bp)Accession Number
Caspase3F: GTGGGATTGAGACGGACAGTGG
R: TTCGCCAGGAATAGTAACCAGGTG
114NM_214131.1
BCL-2F: TGGATGACCGAGTACCTGAA
R: CAGCCAGGAGAAATCAAACA
120NM_001166486.1
BAXF: CACCAAGAAGCTGAGCGAGTGT
R: TCGGAAAAAGACCTCTCGGGGA
118NM_173894
COX2F: GGCTGCGGGAACATAATAGA
R: GCAGCTCTGGGTCAAACTTC
183NM_214321.1
MEKF: TCATCGACTCCATGGCCAAC
R: AGATGTCCGACTGCACGGAGTA
96NM_001244550.1
ERK1F: AGCCCTTTTGAGCATCAGACC
R: AATGACGTTCTCGTGGCGG
84XM_021088019.1
ERK2F: CAAACCTTCCAACCTGCTGC
R: TACTCCGTCAGGAACCCTGT
111XM_021071922.1
C-MOSF: GGTGGTGGCCTACAATCTCC
R: TCAGCTTGTAGAGCGCGAAG
165NM_001113219.1
GDF9F: GTCTCCAACAAGAGAGAGATTC
R: CTGCCAGAAGAGTCATGTTAC
109NM_001001909.1
CDK1F: TAATAAGCTGGGATCTACCACATC
R: TGGCTACCACTTGACCTGTA
130NM_001159304.2
Cyclin BF: AGCTAGTGGTGGCTTCAAGG
R: GCGCCATGACTTCCTGTA
101NM_001170768.1
NANOGF: AGGACAGCCCTGATTCTTCCACAA
R: AAAGTTCTTGCATCTGCTGGAGGC
198XM_021092390.1
CDX2F: AGCCAAGTGAAAACCAGGAC
R: TGCGGTTCTGAAACCAGATT
178NM_001278769.1
SOX2F: GCGGAGTGGAAACTTTTGTCC
R: CGGGAAGCGTGTACTTATCCTT
157NM_001123197.1
OCT4F: GGCTTCAGACTTCGCCTCC
R: AACCTGAGGTCCACAGTATGC
226XM_021097869.1
Caspase9F: GGCCACTGCCTCATCATCAA
R: GGAGGTGGCTGGCCTTG
163XM_013998997.2
GADPHF: CCCAGAATATCATCCCTGCT
R: CTGCTTCACCACCTTCTTGA
185NM_001034034.2
F, forward; R, reverse.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shi, S.; Geng, Z.; Yu, X.; Hu, B.; Liu, L.; Chi, Z.; Qu, L.; Zhang, M.; Jin, Y. Salidroside Supplementation Affects In Vitro Maturation and Preimplantation Embryonic Development by Promoting Meiotic Resumption. Genes 2023, 14, 1729. https://doi.org/10.3390/genes14091729

AMA Style

Shi S, Geng Z, Yu X, Hu B, Liu L, Chi Z, Qu L, Zhang M, Jin Y. Salidroside Supplementation Affects In Vitro Maturation and Preimplantation Embryonic Development by Promoting Meiotic Resumption. Genes. 2023; 14(9):1729. https://doi.org/10.3390/genes14091729

Chicago/Turabian Style

Shi, Shuming, Zhaojun Geng, Xianfeng Yu, Bing Hu, Liying Liu, Zhichao Chi, Linyi Qu, Mingjun Zhang, and Yongxun Jin. 2023. "Salidroside Supplementation Affects In Vitro Maturation and Preimplantation Embryonic Development by Promoting Meiotic Resumption" Genes 14, no. 9: 1729. https://doi.org/10.3390/genes14091729

APA Style

Shi, S., Geng, Z., Yu, X., Hu, B., Liu, L., Chi, Z., Qu, L., Zhang, M., & Jin, Y. (2023). Salidroside Supplementation Affects In Vitro Maturation and Preimplantation Embryonic Development by Promoting Meiotic Resumption. Genes, 14(9), 1729. https://doi.org/10.3390/genes14091729

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop